Bank of New York Mellon’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $339M | Sell |
7,943,553
-1,600,322
| -17% | -$86.9M | 0.06% | 287 |
|
|
2026
Q1 | $599M | Sell |
9,543,875
-1,680,922
| -15% | -$134M | 0.11% | 177 |
|
|
2025
Q4 | $1.07B | Buy |
11,224,797
+191,825
| +2% | +$18.8M | 0.19% | 101 |
|
|
2025
Q3 | $1.08B | Sell |
11,032,972
-175,691
| -2% | -$18.2M | 0.19% | 99 |
|
|
2025
Q2 | $1.2B | Sell |
11,208,663
-545,729
| -5% | -$55.2M | 0.23% | 83 |
|
|
2025
Q1 | $1.19B | Sell |
11,754,392
-701,803
| -6% | -$70.7M | 0.23% | 79 |
|
|
2024
Q4 | $1.11B | Sell |
12,456,195
-1,194,221
| -9% | -$105M | 0.21% | 90 |
|
|
2024
Q3 | $1.14B | Sell |
13,650,416
-1,165,165
| -8% | -$91.8M | 0.21% | 99 |
|
|
2024
Q2 | $1.14B | Sell |
14,815,581
-655,110
| -4% | -$48M | 0.22% | 89 |
|
|
2024
Q1 | $1.06B | Sell |
15,470,691
-1,497,220
| -9% | -$96.3M | 0.2% | 97 |
|
|
2023
Q4 | $981M | Sell |
16,967,911
-239,434
| -1% | -$12.8M | 0.2% | 100 |
|
|
2023
Q3 | $909M | Buy |
17,207,345
+51,293
| +0.3% | +$2.69M | 0.2% | 100 |
|
|
2023
Q2 | $928M | Buy |
17,156,052
+1,374,203
| +9% | +$71.8M | 0.19% | 104 |
|
|
2023
Q1 | $790M | Sell |
15,781,849
-622,120
| -4% | -$29.3M | 0.17% | 127 |
|
|
2022
Q4 | $759M | Buy |
16,403,969
+1,310,418
| +9% | +$56.7M | 0.17% | 122 |
|
|
2022
Q3 | $585M | Buy |
15,093,551
+432,709
| +3% | +$17.4M | 0.14% | 146 |
|
|
2022
Q2 | $546M | Sell |
14,660,842
-1,476,488
| -9% | -$60.1M | 0.12% | 159 |
|
|
2022
Q1 | $715M | Buy |
16,137,330
+2,043,094
| +14% | +$88.5M | 0.14% | 135 |
|
|
2021
Q4 | $599M | Sell |
14,094,236
-680,639
| -5% | -$28.6M | 0.11% | 166 |
|
|
2021
Q3 | $641M | Sell |
14,774,875
-81,124
| -0.5% | -$3.59M | 0.13% | 150 |
|
|
2021
Q2 | $635M | Buy |
14,855,999
+160,777
| +1% | +$6.76M | 0.12% | 147 |
|
|
2021
Q1 | $568M | Sell |
14,695,222
-14,170
| -0.1% | -$536K | 0.12% | 159 |
|
|
2020
Q4 | $529M | Sell |
14,709,392
-369,119
| -2% | -$13.3M | 0.12% | 156 |
|
|
2020
Q3 | $576M | Buy |
15,078,511
+466,225
| +3% | +$18M | 0.14% | 132 |
|
|
2020
Q2 | $513M | Sell |
14,612,286
-187,241
| -1% | -$6.74M | 0.14% | 138 |
|
|
2020
Q1 | $483M | Sell |
14,799,527
-637,334
| -4% | -$24.9M | 0.16% | 129 |
|
|
2019
Q4 | $698M | Sell |
15,436,861
-1,301,715
| -8% | -$54.5M | 0.18% | 108 |
|
|
2019
Q3 | $681M | Sell |
16,738,576
-926,281
| -5% | -$39.2M | 0.19% | 102 |
|
|
2019
Q2 | $759M | Buy |
17,664,857
+570,230
| +3% | +$21.9M | 0.21% | 94 |
|
|
2019
Q1 | $656M | Buy |
17,094,627
+2,057,072
| +14% | +$78.6M | 0.18% | 102 |
|
|
2018
Q4 | $531M | Sell |
15,037,555
-1,224,694
| -8% | -$44.4M | 0.17% | 121 |
|
|
2018
Q3 | $626M | Sell |
16,262,249
-1,888,055
| -10% | -$65.9M | 0.16% | 117 |
|
|
2018
Q2 | $594M | Sell |
18,150,304
-806,143
| -4% | -$24.3M | 0.16% | 118 |
|
|
2018
Q1 | $518M | Buy |
18,956,447
+2,377,505
| +14% | +$64.6M | 0.14% | 135 |
|
|
2017
Q4 | $411M | Sell |
16,578,942
-1,651,780
| -9% | -$45.6M | 0.11% | 189 |
|
|
2017
Q3 | $532M | Sell |
18,230,722
-850,690
| -4% | -$23.5M | 0.15% | 139 |
|
|
2017
Q2 | $529M | Sell |
19,081,412
-223,824
| -1% | -$5.94M | 0.15% | 140 |
|
|
2017
Q1 | $480M | Sell |
19,305,236
-4,623,916
| -19% | -$112M | 0.13% | 156 |
|
|
2016
Q4 | $518M | Buy |
23,929,152
+3,314,820
| +16% | +$72.3M | 0.15% | 135 |
|
|
2016
Q3 | $491M | Sell |
20,614,332
-2,036,727
| -9% | -$48.6M | 0.15% | 145 |
|
|
2016
Q2 | $529M | Sell |
22,651,059
-3,407,989
| -13% | -$73.7M | 0.16% | 133 |
|
|
2016
Q1 | $490M | Buy |
26,059,048
+1,254,252
| +5% | +$22M | 0.15% | 142 |
|
|
2015
Q4 | $457M | Sell |
24,804,796
-1,203,413
| -5% | -$21.6M | 0.14% | 153 |
|
|
2015
Q3 | $427M | Buy |
26,008,209
+1,866,928
| +8% | +$31.9M | 0.13% | 155 |
|
|
2015
Q2 | $427M | Sell |
24,141,281
-2,007,564
| -8% | -$35.9M | 0.12% | 176 |
|
|
2015
Q1 | $464M | Buy |
26,148,845
+7,380,498
| +39% | +$117M | 0.12% | 180 |
|
|
2014
Q4 | $249M | Sell |
18,768,347
-289,966
| -2% | -$3.71M | 0.07% | 323 |
|
|
2014
Q3 | $225M | Sell |
19,058,313
-40,530
| -0.2% | -$510K | 0.06% | 327 |
|
|
2014
Q2 | $244M | Buy |
19,098,843
+5,291,388
| +38% | +$68.8M | 0.07% | 311 |
|
|
2014
Q1 | $187M | Sell |
13,807,455
-45,974
| -0.3% | -$603K | 0.05% | 372 |
|
|
2013
Q4 | $167M | Sell |
13,853,429
-629,948
| -4% | -$7.44M | 0.05% | 392 |
|
|
2013
Q3 | $170M | Buy |
14,483,377
+69,540
| +0.5% | +$752K | 0.05% | 380 |
|
|
2013
Q2 | $134M | Buy |
+14,413,837
| New | +$122M | 0.04% | 431 |
|
Other funds holding BSX
N
Bank of New York Mellon's BSX Position: Q2 2026 in Review
Bank of New York Mellon reduced its Boston Scientific (BSX) stake by 17% in Q2 2026, selling an estimated $86.9M and leaving 7,943,553 shares worth $339M. The position accounts for 0.06% of the portfolio, ranked #287.
Bank of New York Mellon first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.2B in Q2 2025. 869 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Bank of New York Mellon held 7,943,553 shares of Boston Scientific worth $339M as of Q2 2026.
- Bank of New York Mellon sold 1,600,322 Boston Scientific shares in Q2 2026, an estimated $86.9M.
- Boston Scientific made up 0.06% of Bank of New York Mellon's portfolio in Q2 2026, its #287 holding.
- Bank of New York Mellon first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Boston Scientific position peaked at $1.2B in Q2 2025.
- 869 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.